---
new study criticizes painkiller MARKETING
New study criticizes painkiller MARKETING -- Posted by firechief on 01-25-05 12:49
New Studies Add to Data That Put Arthritis
Drugs on Hot Seat
01-25-2005 4:22 AM
By LINDSEY TANNER
CHICAGO -- Merck & Co. forced one of its researchers to
remove her name from a study linking Vioxx to heart attacks,
then criticized the findings before ultimately pulling the
arthritis drug from the market last fall, two of the
scientist's colleagues said.
"Even after funding and agreeing with the design of the
study, Merck publicly discredited our findings," Drs. Daniel
Solomon and Jerry Avorn of Boston's Brigham and Women's
Hospital wrote in this week's Archives of Internal Medicine.
Merck spokeswoman Anita Larsen confirmed the company's
action, saying Merck believed the study's conclusions "were
not supported by the data." The incident came about six
months before another study prompted the drugmaker to
withdraw Vioxx.
The journal contains several studies about Vioxx and
Celebrex, the once popular and heavily promoted painkillers
advertised as stomach-friendly alternatives to aspirin. They
are under congressional and regulatory scrutiny.
One new report echoes previous data suggesting that in some
older patients the drugs might not offer as much protection
as thought against gastrointestinal problems. A separate
study suggests they have been over-prescribed, frequently to
patients at low risk for GI problems. And other research
supports evidence that Vioxx increases some patients' blood
pressure.
Vioxx was withdrawn Sept. 30 because of a study suggesting
it doubled the risk of heart attack and stroke. Celebrex
maker Pfizer Inc. halted its ads last month after a study
linked high doses with increased heart and stroke risks.
Both drugs are in a class called Cox-2 inhibitors. The
Archives reports, published Monday, come just weeks before
a Feb. 16-18 Food and Drug Administration meeting on the
safety of all Cox-2 drugs. Also Monday, the watchdog group
Public Citizen petitioned the FDA to immediately remove from
the market Celebrex and a related drug, Bextra, because of
the potential heart risks.
Critics contend Merck attempted for years to suppress Vioxx
risks found in numerous studies. The company maintains it
has acted responsibly. The incident, mentioned in previous
news reports, involved a Merck study of more than 50,000
patients age 65+ taking Vioxx, Celebrex, traditional pain-
killers or none of the drugs. The results, published last
year in the journal Circulation, showed Vioxx patients faced
a higher heart attack risk than the other groups.
When the results came in, "Merck required a co-author who
was an employee of the company to remove her name from the
article immediately prior to publication," Solomon and Avorn
said in an Archives editorial.
Solomon identified the co-author as Merck epidemiologist
Carolyn Cannuscio. She did not respond to e-mail and
telephone requests for comment.
Larsen said publication policies at Circulation and Merck
allowed the drugmaker to remove the employee's name "if
the authors draw conclusions that are not supported by the
data." She said Cannuscio agreed with Merck's decision.
Meanwhile, the British medical journal Lancet is releasing a
study on the heart dangers of Vioxx after withholding the report
because the researcher said he had been threatened by his
superiors at the FDA.
The study links Vioxx to between 88,000 and 140,000 excess
cases of heart disease in the United States _ a conclusion
that has previously been disclosed.
Dr. David Graham, who works in the FDA's office of drug
safety, claimed he was threatened with dismissal and said he
asked the Lancet to withdraw the paper from publication in
November.
Earlier this month, the FDA agreed the study could be
published.
___
On the Net:
Archives of Internal Medicine:
http://archinternmed.com
Re: new study criticizes painkiller MARKETING -- Posted by Zee on 01-25-05 09:59
I enquired about donating for bone marrow transplant, but unfortunately
they will not accept me because I have had statin-induced mitochondrial
myopathy.
I volunteer to help them with their promotional material.
Take care. I wish you well.
Zee
Re: new study criticizes painkiller MARKETING -- Posted by firechief on 01-25-05 12:44
spodosaurus wrote and asked:
> LOL
>
> Where do you people come from? :-)
Consumer Group Urges FDA to Order Pain Killers
Celebrex and Bextra Off the Market
01-25-2005 4:23 AM
WASHINGTON -- A consumer group urged the Food and Drug
Administration on Monday to order the pain killers Celebrex
and Bextra off the market. Public Citizen charged that the two
drugs from Pfizer Inc. increase the likelihood of heart attack.
Celebrex and Bextra are part of the family of drugs known
as COX-2 inhibitors. Another drug in that group, Vioxx, was
withdrawn last fall by its manufacturer, Merck & Co.,
because of heart problems.
Similar concerns have been expressed about Celebrex and
Bextra, but they remain on the market.
Neither the FDA nor Pfizer responded immediately to
requests for comment on Public Citizen's petition.
COX-2 inhibitors have been widely popular for use as pain
killers and anti-inflammatory drugs with fewer stomach and
intestinal side effects than such products as aspirin.
___
On the Net:
Public Citizen: http://www.publiccitizen.org
Food and Drug Administration: http://www.fda.gov
Re: new study criticizes painkiller MARKETING -- Posted by Nann Bell on 01-25-05 18:58
Oh, yeah, the same folks who tried to get Arava killed a couple of years ago.
I remember writing a fervent letter to the FDA on that one. I used to
like Ralph Nader but I think his crusader image has long since gone to his
head.
I asked my RD about it all last week. He just said that the study was on
bypass patients and he wasn't worried about anyone with an ok heart.
--
Nann
remove the Gator cheer to email me
Simply the thing I am shall make me live --- William Shakespeare
> Consumer Group Urges FDA to Order Pain Killers
> Celebrex and Bextra Off the Market
> 01-25-2005 4:23 AM
>
> WASHINGTON -- A consumer group urged the Food and Drug
> Administration on Monday to order the pain killers Celebrex
> and Bextra off the market. Public Citizen charged that the two
> drugs from Pfizer Inc. increase the likelihood of heart attack.
>
> Celebrex and Bextra are part of the family of drugs known
> as COX-2 inhibitors. Another drug in that group, Vioxx, was
> withdrawn last fall by its manufacturer, Merck & Co.,
> because of heart problems.
>
> Similar concerns have been expressed about Celebrex and
> Bextra, but they remain on the market.
>
> Neither the FDA nor Pfizer responded immediately to
> requests for comment on Public Citizen's petition.
>
> COX-2 inhibitors have been widely popular for use as pain
> killers and anti-inflammatory drugs with fewer stomach and
> intestinal side effects than such products as aspirin.
>
> ___
>
> On the Net:
> Public Citizen: http://www.publiccitizen.org
> Food and Drug Administration: http://www.fda.gov
>
>
Start
« Previous 1 2
Related
Discussion:
Desperate for Help?? (3 posts)
by producer - Last post on: 01-25-05 06:40
Are you desperate for help with your arthritis? Has the loss of Vioxx
and other popular, pain-relieving drugs left you willing to do almost
anything for help?
If you answered yes to either of those questions and you live in the
Washington, D.C. area, then we might want to talk to you.
ABC 7 New... (Read More)
management of insulin and food (6 posts)
by Isabelle Penman - Last post on: 12-16-04 18:58
Does anyone have an idea how to manage food and insulin around an irregular
schedule? I have insomnia and I can literally be awake or asleep at any
hour of the day and night.
I talked to my Dr, and I dont think he understood at all. He got very
impatient with me when I told him I cant tell nig... (Read More)
Chromium.Vital to Diabetics (2 posts)
by STABLE1001 - Last post on: 06-30-04 13:39
Dear gentle reader,
Diabetes
Chromium is an important mineral for diabetics, as it is required for
normal function. When the body has no Chromium defciency, it can
produce symptoms, such as impaired glucose metabolism, highblood sugar
levels, and lower HDL levels. Gymnema sylvestre also pla... (Read More)
amqgriukfs (1 posts)
by Toran - Last post on: 07-08-04 18:06
amqgriukfs
representitive amqgriukfs
presentable amqgriukfs
terayon amqgriukfs
e lunsen amqgriukfs
gadalke amqgriukfs
gomer amqgriukfs
prudenter amqgriukfs
gloriuos amqgriukfs
iciaire amqgriukfs
eachother amqgriukfs
desparation amqgriukfs
mailbombs amqgriukfs
sergei smith amqgriukfs
in... (Read More)
Top
Discussions From Our Archives
Any Insights to Companys that give free glucose meters
Waterfall D-Mannose for Bladder Infections
Risk Of Chronic Heart Failure With Insulin Sensitizers
Obesity Treatment: The Key to Managing the Type 2 Diabetes Time bomb?
How long does it take to heal
Other
Discussion Categories
Diabetes Symptoms
Health Care Policy
| 
